Gerresheimer AG (ETR:GXI)
Market Cap | 2.59B |
Revenue (ttm) | 2.04B |
Net Income (ttm) | 109.72M |
Shares Out | 34.54M |
EPS (ttm) | 3.18 |
PE Ratio | 23.61 |
Forward PE | 13.91 |
Dividend | 1.25 (1.67%) |
Ex-Dividend Date | Jun 6, 2025 |
Volume | 17,367 |
Average Volume | 254,197 |
Open | 74.75 |
Previous Close | 75.00 |
Day's Range | 74.70 - 75.85 |
52-Week Range | 62.90 - 109.70 |
Beta | 0.92 |
RSI | 42.49 |
Earnings Date | Apr 11, 2025 |
About Gerresheimer AG
Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufactu... [Read more]
Financial Performance
In 2024, Gerresheimer AG's revenue was 2.04 billion, an increase of 2.28% compared to the previous year's 1.99 billion. Earnings were 109.72 million, a decrease of -5.52%.
Financial StatementsNews

Exclusive: KKR, Warburg Pincus group submitted non-binding bid for Gerresheimer, sources say
A consortium including KKR and Warburg Pincus has submitted a non-binding bid for Gerresheimer AG , which makes pens used to inject weight loss drugs like Wegovy, two people with knowledge of the matt...

Warburg Pincus, KKR in Advanced Talks to Buy Gerresheimer
A consortium consisting of Warburg Pincus and KKR & Co. are in talks to acquire Gerresheimer AG, the German maker of packaging for drugs and cosmetics.
KKR, Warburg Picus in talks to acquire Gerresheimer - Bloomberg

Warburg Pincus, KKR in talks to buy medical packaging maker Gerresheimer, Bloomberg News reports
A consortium consisting of Warburg Pincus and KKR are in talks to acquire German medical packaging maker Gerresheimer AG , Bloomberg News reported on Wednesday citing people familiar with the matter.
Gerresheimer AG (GRRMY) Q4 2024 Earnings Call Highlights: Strong Q4 Performance Amid Strategic ...
Gerresheimer AG (GRRMY) Q4 2024 Earnings Call Highlights: Strong Q4 Performance Amid Strategic Shifts
Gerresheimer AG (GRRMF) Q4 2024 Earnings Call Transcript
Gerresheimer AG reports Q4 results

Gerresheimer slashes revenue guidance for 2025 in half
German packaging and medical equipment maker Gerresheimer halved its guidance for 2025 on Wednesday.

Gerresheimer Thrives in 2024: Solid Results Amid Market Challenges
In 2024, Gerresheimer showcased resilience with notable financial achievements and promising future prospects, despite market hurdles. Jetzt den vollständigen Artikel lesen

EQS-News: Gerresheimer delivers solid results in the financial year 2024 despite market headwinds
EQS-News: Gerresheimer AG / Key word(s): Annual Results Gerresheimer delivers solid results in the financial year 2024 despite market headwinds 26.02.2025 / 07:00 CET/CEST The issuer is solely respons...

Gerresheimer draws interest from Phillips-Medisize and Bain, Bloomberg News reports
German medical packaging maker Gerresheimer has garnered interest from US medical solutions company Phillips-Medisize and buyout firm Bain Capital for parts or all of Gerresheimer, Bloomberg News repo...

EQS-Adhoc: Gerresheimer AG confirms discussions with private equity investors on potential takeover offer
EQS-Ad-hoc: Gerresheimer AG / Key word(s): Tender Offer Gerresheimer AG confirms discussions with private equity investors on potential takeover offer 07-Feb-2025 / 16:26 CET/CEST Disclosure of an ins...

German packaging firm Gerresheimer exploring sale, Bloomberg News reports
German medical packaging maker Gerresheimer is exploring a potential sale amid interest from private equity funds, Bloomberg News reported on Friday, citing people familiar with the matter.

Gerresheimer: FDA grants Tentative Approval of SQ Innovation's Lasix® ONYU* (FOTO)
Düsseldorf (ots) - - Innovative combination product of furosemide and on-body device - Ready-to-market device designed, developed and manufactured by Gerresheimer - Patented device technology for prec...

EQS-News: Gerresheimer: FDA grants Tentative Approval of SQ Innovation’s Lasix ONYU*
EQS-News: Gerresheimer AG / Key word(s): Miscellaneous/Regulatory Admission Gerresheimer: FDA grants Tentative Approval of SQ Innovation’s Lasix ONYU* 16.12.2024 / 09:00 CET/CEST The issuer is solely ...

Gerresheimer Seals Deal: Acquires Bormioli Pharma's Holding Company
Gerresheimer AG has bolstered its market presence by acquiring Blitz LuxCo Sarl, the parent of Bormioli Pharma Group, enhancing its European production and product offerings in the pharma and biotech ...

EQS-News: Gerresheimer builds new production capacities for glass syringes at Skopje site
EQS-News: Gerresheimer AG / Key word(s): Expansion Gerresheimer builds new production capacities for glass syringes at Skopje site 02.12.2024 / 13:30 CET/CEST The issuer is solely responsible for the ...

EQS-DD: Gerresheimer AG: Dietmar Siemssen, buy
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 13.11.2024 / 17:56 CET/CEST The issuer is solely responsi...

EQS-News: Solar power for Gerresheimer site in Momignies, Belgium
EQS-News: Gerresheimer AG / Key word(s): ESG Solar power for Gerresheimer site in Momignies, Belgium 14.10.2024 / 11:00 CET/CEST The issuer is solely responsible for the content of this announcement. ...
Gerresheimer AG (GRRMY) Q3 2024 Earnings Call Highlights: Navigating Growth Amid Challenges
Gerresheimer AG (GRRMY) Q3 2024 Earnings Call Highlights: Navigating Growth Amid Challenges

Gerresheimer shares jump as activist investor buys over 5% stake
Gerresheimer's shares rose as much as 6.8% on Wednesday after a regulatory filing showed activist investor Ricky Chad Sandler had bought a 5.43% stake in German medical packaging maker.

Gerresheimer AG Slashes Growth Forecast for 2024 and 2025
Gerresheimer AG revises its 2024 and 2025 growth forecasts due to slower market recovery and Hurricane Helene's impact on its US vial plant. Join their conference call on September 30, 2024, for more ...

EQS-Adhoc: Gerresheimer AG: Adjustment of growth guidance for 2024 and 2025
EQS-Ad-hoc: Gerresheimer AG / Key word(s): Change in Forecast/Development of Sales Gerresheimer AG: Adjustment of growth guidance for 2024 and 2025 30-Sep-2024 / 16:21 CET/CEST Disclosure of an inside...

Stevanato Group, Gerresheimer and SCHOTT Pharma, Announce Strategic Industry “Alliance for RTU”
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, together w...

EQS-News: SCHOTT Pharma, Gerresheimer, and Stevanato Group announce strategic industry “Alliance for RTU”
EQS-News: SCHOTT Pharma AG & Co. KGaA / Key word(s): Agreement SCHOTT Pharma, Gerresheimer, and Stevanato Group announce strategic industry “Alliance for RTU” 26.09.2024 / 12:30 CET/CEST The issuer is...